Johannes C. Huber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Johannes C. Huber has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Clemens Tempfer
Abteilung für Geburtshilfe und Frauenheilkunde, Marien Hospital Herne und Ruhr-Universität Bochum, Bochum, Deutschland
8 shared publications - Johannes Ott
Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin, Medizinische Universität Wien, Wien, Österreich
7 shared publications - Kazem Nouri
Department of Gynecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, Vienna, Austria
5 shared publications - Christine Kurz
Department of Gynecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, Vienna, Austria
2 shared publications - Eva-Katrin Bentz
Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria
2 shared publications - Klaus Mayerhofer
Department of Gynecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, Vienna, Austria
2 shared publications
Latest Publications
- 1 December 2015
- Published by Springer Nature
- p. 185-194
The Importance of Isoflavones for Women’s Health
- 1 December 2015
- Published by Springer Nature
- p. 185-194
The Importance of Isoflavones for Women’s Health
- 24 October 2013
- Published by Georg Thieme Verlag KG in Erfahrungsheilkunde
- Vol. 62 (05) , 260-265
Sojaextrakte bei gynäkologischen Tumoren
Lange wurde das Östrogen Estradiol als das große Gift des weiblichen Körpers angesehen, und auch Pflanzenöstrogene galten als bedenklich. Aktuelle Studien belegen nicht nur das Gegenteil, sondern die in Soja enthaltenen Phytohormone haben sogar protektive Effekte. Der Schutzmechanismus korreliert aber v. a. mit der Konzentration im Blut. Neben dem Einfluss der Östrogenrezeptoren erläutert der Autor den Metabolismus des Hormons und erklärt die Effekte von Sojaextrakt auf onkologische Vorgänge. For a long time, the estrogen estradiol has been regarded as the major poison of the female body and even vegetable estrogens were considered to be suspicious. Present studies not only prove the opposite, they also show, that the phytohormones contained in soy have protective effects. The protective mechanism however correlates especially with the concentration in the blood. In addition to the influence of the estrogen receptors, the author illustrates the metabolism of the hormone and explains the effect, soy extract has on oncological processes.
- 24 October 2013
- Published by Georg Thieme Verlag KG in Erfahrungsheilkunde
- Vol. 62 (05) , 260-265
Sojaextrakte bei gynäkologischen Tumoren
Lange wurde das Östrogen Estradiol als das große Gift des weiblichen Körpers angesehen, und auch Pflanzenöstrogene galten als bedenklich. Aktuelle Studien belegen nicht nur das Gegenteil, sondern die in Soja enthaltenen Phytohormone haben sogar protektive Effekte. Der Schutzmechanismus korreliert aber v. a. mit der Konzentration im Blut. Neben dem Einfluss der Östrogenrezeptoren erläutert der Autor den Metabolismus des Hormons und erklärt die Effekte von Sojaextrakt auf onkologische Vorgänge. For a long time, the estrogen estradiol has been regarded as the major poison of the female body and even vegetable estrogens were considered to be suspicious. Present studies not only prove the opposite, they also show, that the phytohormones contained in soy have protective effects. The protective mechanism however correlates especially with the concentration in the blood. In addition to the influence of the estrogen receptors, the author illustrates the metabolism of the hormone and explains the effect, soy extract has on oncological processes.
- Open Access
- 21 May 2010
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 8 (1) , 1-8
Reproductive outcome after hysteroscopic septoplasty in patients with septate uterus - a retrospective cohort study and systematic review of the literature
Background: Septate uterus, one of the most common forms of congenital uterine malformations, negatively affects female reproductive health. Methods: In a retrospective cohort study, we evaluated the reproductive outcome after hysteroscopic septoplasty in 64 women with septate uterus and primary or secondary infertility. We performed a systematic review of studies evaluating the reproductive outcome after hysteroscopic septoplasty. Results: Sixty-four women underwent hysteroscopic septoplasty. In 2/64 (3%) women, intraoperative uterine perforation occurred. Complete follow-up was available for 49/64 (76%) patients. Mean follow-up time was 68.6 +/- 5.2 months. The overall pregnancy rate after hysteroscopic septoplasty was 69% (34/49). The overall life birth rate (LBR) was 49% (24/49). The mean time interval between surgery and the first life birth was 35.8 +/- 22.5 months. Including our own data, we identified 18 studies investigating the effect of septoplasty on reproductive outcome in 1501 women. A pooled analysis demonstrated that hysteroscopic septoplasty resulted in an overall pregnancy rate of 60% (892/1501) and a LBR of 45% (686/1501). The overall rate of intra- and postoperative complications was 1.7% (23/1324) and the overall rate of re-hysteroscopy was 6% (79/1324). Conclusions: In women with septate uterus and a history of infertility, hysteroscopic septoplasty is a safe and effective procedure resulting in a pregnancy rate of 60% and a LBR of 45%.
- 21 May 2010
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 8 (1) , 1-8
Open AccessReproductive outcome after hysteroscopic septoplasty in patients with septate uterus - a retrospective cohort study and systematic review of the literature
Background: Septate uterus, one of the most common forms of congenital uterine malformations, negatively affects female reproductive health. Methods: In a retrospective cohort study, we evaluated the reproductive outcome after hysteroscopic septoplasty in 64 women with septate uterus and primary or secondary infertility. We performed a systematic review of studies evaluating the reproductive outcome after hysteroscopic septoplasty. Results: Sixty-four women underwent hysteroscopic septoplasty. In 2/64 (3%) women, intraoperative uterine perforation occurred. Complete follow-up was available for 49/64 (76%) patients. Mean follow-up time was 68.6 +/- 5.2 months. The overall pregnancy rate after hysteroscopic septoplasty was 69% (34/49). The overall life birth rate (LBR) was 49% (24/49). The mean time interval between surgery and the first life birth was 35.8 +/- 22.5 months. Including our own data, we identified 18 studies investigating the effect of septoplasty on reproductive outcome in 1501 women. A pooled analysis demonstrated that hysteroscopic septoplasty resulted in an overall pregnancy rate of 60% (892/1501) and a LBR of 45% (686/1501). The overall rate of intra- and postoperative complications was 1.7% (23/1324) and the overall rate of re-hysteroscopy was 6% (79/1324). Conclusions: In women with septate uterus and a history of infertility, hysteroscopic septoplasty is a safe and effective procedure resulting in a pregnancy rate of 60% and a LBR of 45%.
- Open Access
- 22 April 2010
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 8 (1) , 1-7
OCT-4 expression in follicular and luteal phase endometrium: a pilot study
Background: The stem cell marker Octamer-4 (OCT-4) is expressed in human endometrium. Menstrual cycle-dependency of OCT-4 expression has not been investigated to date. Methods: In a prospective, single center cohort study of 98 women undergoing hysteroscopy during the follicular (n = 49) and the luteal (n = 40) phases of the menstrual cycle, we obtained endometrial samples. Specimens were investigated for OCT-4 expression on the mRNA and protein levels using reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemistry. Expression of OCT-4 was correlated to menstrual cycle phase. Results: Of 89 women sampled, 49 were in the follicular phase and 40 were in the luteal phase. OCT-4 mRNA was detected in all samples. Increased OCT-4 mRNA levels in the follicular and luteal phases was found in 35/49 (71%) and 27/40 (68%) of women, respectively (p = 0.9). Increased expression of OCT-4 protein was identified in 56/89 (63%) samples. Increased expression of OCT-4 protein in the follicular and luteal phases was found in 33/49 (67%) and 23/40 (58%) of women, respectively (p = 0.5). Conclusions: On the mRNA and protein levels, OCT-4 is not differentially expressed during the menstrual cycle. Endometrial OCT-4 is not involved in or modulated by hormone-induced cyclical changes of the endometrium.
- 22 April 2010
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 8 (1) , 1-7
Open AccessOCT-4 expression in follicular and luteal phase endometrium: a pilot study
Background: The stem cell marker Octamer-4 (OCT-4) is expressed in human endometrium. Menstrual cycle-dependency of OCT-4 expression has not been investigated to date. Methods: In a prospective, single center cohort study of 98 women undergoing hysteroscopy during the follicular (n = 49) and the luteal (n = 40) phases of the menstrual cycle, we obtained endometrial samples. Specimens were investigated for OCT-4 expression on the mRNA and protein levels using reverse transcriptase polymerase chain reaction (RT-PCR) and immunohistochemistry. Expression of OCT-4 was correlated to menstrual cycle phase. Results: Of 89 women sampled, 49 were in the follicular phase and 40 were in the luteal phase. OCT-4 mRNA was detected in all samples. Increased OCT-4 mRNA levels in the follicular and luteal phases was found in 35/49 (71%) and 27/40 (68%) of women, respectively (p = 0.9). Increased expression of OCT-4 protein was identified in 56/89 (63%) samples. Increased expression of OCT-4 protein in the follicular and luteal phases was found in 33/49 (67%) and 23/40 (58%) of women, respectively (p = 0.5). Conclusions: On the mRNA and protein levels, OCT-4 is not differentially expressed during the menstrual cycle. Endometrial OCT-4 is not involved in or modulated by hormone-induced cyclical changes of the endometrium.
- Open Access
- 1 January 2010
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 8 (1) , 85
Family incidence of endometriosis in first-, second-, and third-degree relatives: case-control study
Initial publications examining the hereditary aspects of endometriosis appeared in the early seventies and demonstrated an up to seven-fold risk for endometriosis in first-degree relatives of endometriosis patients. The aim was to evaluate the influence of hereditary aspects on the endometriosis risk in our patient collective.
- 1 January 2010
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 8 (1) , 85
Open AccessFamily incidence of endometriosis in first-, second-, and third-degree relatives: case-control study
Initial publications examining the hereditary aspects of endometriosis appeared in the early seventies and demonstrated an up to seven-fold risk for endometriosis in first-degree relatives of endometriosis patients. The aim was to evaluate the influence of hereditary aspects on the endometriosis risk in our patient collective.
- Open Access
- 1 January 2010
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 8 (1) , 45
Pregnancy outcome in women with polycystic ovary syndrome comparing the effects of laparoscopic ovarian drilling and clomiphene citrate stimulation in women pre-treated with metformin: a retrospective study
Ovarian stimulation in women with polycystic ovary syndrome (PCOS) increases the risk for perinatal complications. Ovulation induction by laparoscopic ovarian drilling (LOD) might improve the overall pregnancy outcomes. The aim of our study was to assess the adverse events or effects on pregnancy of LOD and clomiphene citrate (CC) stimulation in patients who received metformin.
- 1 January 2010
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 8 (1) , 45
Open AccessPregnancy outcome in women with polycystic ovary syndrome comparing the effects of laparoscopic ovarian drilling and clomiphene citrate stimulation in women pre-treated with metformin: a retrospective study
Ovarian stimulation in women with polycystic ovary syndrome (PCOS) increases the risk for perinatal complications. Ovulation induction by laparoscopic ovarian drilling (LOD) might improve the overall pregnancy outcomes. The aim of our study was to assess the adverse events or effects on pregnancy of LOD and clomiphene citrate (CC) stimulation in patients who received metformin.
- 1 January 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (1) , 68-71
Multiple site sampling does not increase the sensitivity of Chlamydia trachomatis detection in infertility patients
- 1 January 2010
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (1) , 68-71
Multiple site sampling does not increase the sensitivity of Chlamydia trachomatis detection in infertility patients
- Open Access
- 30 December 2009
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 7 (1) , 1-7
Luteinizing hormone and androstendione are independent predictors of ovulation after laparoscopic ovarian drilling: a retrospective cohort study
Our objective was to investigate luteinizing hormone, follicle-stimulating hormone, testosterone, and androstenedione as predicitve markers for ovulation after laparoscopic ovarian drilling. We retrospectively analyzed 100 clompihen-resistant patients with the polycystic ovary syndrome who underwent laparoscopic ovarian drilling at our department. The main outcome measure was spontaneous postoperative ovulation within three months after laparoscopic ovarian drilling. In order to predict spontaneous ovulation, we tested the following parameters by use of a univariate followed by a multivariate regression model: Preoperative serum levels of LH, FSH, testosterone, and androstenedione as well as patients' age and body mass index. In addition, we focused on pregnancy and life birth rates. Spontaneous ovulation was documented in 71/100 patients (71.0%). In a univariate and multivariate analysis, luteinizing hormone (OR 1.58, 95%CI: 1.30-1.92) and androstenedione (OR 3.03, 95%CI: 1.20-7.67), but not follicle-stimulating hormone and testosterone were independent predictors of ovulation. Using a cut-off for luteinizing hormone and androstenedione of 12.1 IU/l and 3.26 ng/ml, respectively, spontaneous ovulation was observed in 63/70 (90.0%) and 36/42 patients (85.7%) with elevated and in 8/30 (26.7%) and 35/58 (60.3%) patients with low luteinizing hormone and androstenedione levels, respectively. The sensitivity, specificity, positive and negatvie predictive values for luteinizing hormone and androstendione as predictors of spontaneous ovulation after ovarian drilling were 88.7% (95%CI: 79.0-95.0%), 75.9% (95%CI: 56.5-89.7%), 90.0% (95%CI: 80.5-95.8%), and 73.3% (95%CI: 54.1-87.7%) for luteinizing hormone, and 50.7% (95%CI: 38.6-62.8%), 79.3% (95%CI: 60.3-92.0%), 85.7% (95%CI: 71.5-94.6%), and 39.7% (95%CI: 27.0-53.4%) for androstenedione, respectively. Complete one-year follow-up was available for 74/100 patients (74%). We observed a one-year pregnancy rate and a resulting life-birth rate of 61% and 51%, respectively. Luteinizing hormone and androstenedione prior to laparoscopic ovarian drilling are independent predictors of spontaneous ovulation within three months of surgery. We suggest to preferentially performing laparoscopic ovarian drilling in patients with high luteinizing hormone and androstenedione levels.
- 30 December 2009
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 7 (1) , 1-7
Open AccessLuteinizing hormone and androstendione are independent predictors of ovulation after laparoscopic ovarian drilling: a retrospective cohort study
Our objective was to investigate luteinizing hormone, follicle-stimulating hormone, testosterone, and androstenedione as predicitve markers for ovulation after laparoscopic ovarian drilling. We retrospectively analyzed 100 clompihen-resistant patients with the polycystic ovary syndrome who underwent laparoscopic ovarian drilling at our department. The main outcome measure was spontaneous postoperative ovulation within three months after laparoscopic ovarian drilling. In order to predict spontaneous ovulation, we tested the following parameters by use of a univariate followed by a multivariate regression model: Preoperative serum levels of LH, FSH, testosterone, and androstenedione as well as patients' age and body mass index. In addition, we focused on pregnancy and life birth rates. Spontaneous ovulation was documented in 71/100 patients (71.0%). In a univariate and multivariate analysis, luteinizing hormone (OR 1.58, 95%CI: 1.30-1.92) and androstenedione (OR 3.03, 95%CI: 1.20-7.67), but not follicle-stimulating hormone and testosterone were independent predictors of ovulation. Using a cut-off for luteinizing hormone and androstenedione of 12.1 IU/l and 3.26 ng/ml, respectively, spontaneous ovulation was observed in 63/70 (90.0%) and 36/42 patients (85.7%) with elevated and in 8/30 (26.7%) and 35/58 (60.3%) patients with low luteinizing hormone and androstenedione levels, respectively. The sensitivity, specificity, positive and negatvie predictive values for luteinizing hormone and androstendione as predictors of spontaneous ovulation after ovarian drilling were 88.7% (95%CI: 79.0-95.0%), 75.9% (95%CI: 56.5-89.7%), 90.0% (95%CI: 80.5-95.8%), and 73.3% (95%CI: 54.1-87.7%) for luteinizing hormone, and 50.7% (95%CI: 38.6-62.8%), 79.3% (95%CI: 60.3-92.0%), 85.7% (95%CI: 71.5-94.6%), and 39.7% (95%CI: 27.0-53.4%) for androstenedione, respectively. Complete one-year follow-up was available for 74/100 patients (74%). We observed a one-year pregnancy rate and a resulting life-birth rate of 61% and 51%, respectively. Luteinizing hormone and androstenedione prior to laparoscopic ovarian drilling are independent predictors of spontaneous ovulation within three months of surgery. We suggest to preferentially performing laparoscopic ovarian drilling in patients with high luteinizing hormone and androstenedione levels.
- 21 August 2009
- Published by Springer Nature
- p. 285-314
Estrogen-Metabolizing Gene Polymorphisms, Genetic Susceptibility, and Pharmacogenomics
- 21 August 2009
- Published by Springer Nature
- p. 285-314
Estrogen-Metabolizing Gene Polymorphisms, Genetic Susceptibility, and Pharmacogenomics